

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 8.84162366 |
| 2 | surfactant homeostasis (GO:0043129) | 8.61496566 |
| 3 | axonemal dynein complex assembly (GO:0070286) | 7.73971651 |
| 4 | chemical homeostasis within a tissue (GO:0048875) | 7.14348527 |
| 5 | ensheathment of neurons (GO:0007272) | 6.99670860 |
| 6 | axon ensheathment (GO:0008366) | 6.99670860 |
| 7 | myelination (GO:0042552) | 6.94951793 |
| 8 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.10445684 |
| 9 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.66002759 |
| 10 | primary alcohol catabolic process (GO:0034310) | 5.61847599 |
| 11 | cilium movement (GO:0003341) | 5.35687677 |
| 12 | cholesterol biosynthetic process (GO:0006695) | 5.34597739 |
| 13 | myelin maintenance (GO:0043217) | 5.29365511 |
| 14 | creatine metabolic process (GO:0006600) | 5.07527049 |
| 15 | motile cilium assembly (GO:0044458) | 4.98678718 |
| 16 | multicellular organismal water homeostasis (GO:0050891) | 4.94380412 |
| 17 | ethanol metabolic process (GO:0006067) | 4.86864145 |
| 18 | vitamin transmembrane transport (GO:0035461) | 4.84362718 |
| 19 | sterol biosynthetic process (GO:0016126) | 4.72255163 |
| 20 | oligodendrocyte differentiation (GO:0048709) | 4.69598063 |
| 21 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.69584488 |
| 22 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.63984323 |
| 23 | regulation of collateral sprouting (GO:0048670) | 4.63285594 |
| 24 | desmosome organization (GO:0002934) | 4.52906495 |
| 25 | one-carbon compound transport (GO:0019755) | 4.51210108 |
| 26 | amyloid precursor protein metabolic process (GO:0042982) | 4.38787774 |
| 27 | negative regulation of neurotransmitter transport (GO:0051589) | 4.23854338 |
| 28 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.23309533 |
| 29 | ethanol oxidation (GO:0006069) | 4.22172708 |
| 30 | glycerophospholipid catabolic process (GO:0046475) | 4.21212922 |
| 31 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.20444469 |
| 32 | epithelial cilium movement (GO:0003351) | 4.19377918 |
| 33 | water homeostasis (GO:0030104) | 4.19297034 |
| 34 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.16070289 |
| 35 | response to methylmercury (GO:0051597) | 4.12353123 |
| 36 | substantia nigra development (GO:0021762) | 4.09115413 |
| 37 | establishment of mitochondrion localization (GO:0051654) | 4.09112196 |
| 38 | cellular response to nitric oxide (GO:0071732) | 4.06286384 |
| 39 | intestinal epithelial cell development (GO:0060576) | 4.04980791 |
| 40 | isoprenoid biosynthetic process (GO:0008299) | 4.04767427 |
| 41 | response to redox state (GO:0051775) | 4.04388043 |
| 42 | negative regulation of protein localization to cell surface (GO:2000009) | 4.00245202 |
| 43 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.97272295 |
| 44 | sodium ion homeostasis (GO:0055078) | 3.95761700 |
| 45 | adhesion of symbiont to host cell (GO:0044650) | 3.95476933 |
| 46 | virion attachment to host cell (GO:0019062) | 3.95476933 |
| 47 | photoreceptor cell differentiation (GO:0046530) | 3.94143122 |
| 48 | eye photoreceptor cell differentiation (GO:0001754) | 3.94143122 |
| 49 | axoneme assembly (GO:0035082) | 3.91608125 |
| 50 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.89825671 |
| 51 | establishment of apical/basal cell polarity (GO:0035089) | 3.86975791 |
| 52 | apical protein localization (GO:0045176) | 3.86583719 |
| 53 | very long-chain fatty acid metabolic process (GO:0000038) | 3.83086220 |
| 54 | tight junction assembly (GO:0070830) | 3.82252466 |
| 55 | astrocyte development (GO:0014002) | 3.76458991 |
| 56 | asymmetric protein localization (GO:0008105) | 3.74661885 |
| 57 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.72783513 |
| 58 | L-phenylalanine catabolic process (GO:0006559) | 3.72597967 |
| 59 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.72597967 |
| 60 | L-amino acid import (GO:0043092) | 3.61574464 |
| 61 | heme transport (GO:0015886) | 3.61045893 |
| 62 | response to lipoprotein particle (GO:0055094) | 3.53256382 |
| 63 | myelination in peripheral nervous system (GO:0022011) | 3.52946781 |
| 64 | peripheral nervous system axon ensheathment (GO:0032292) | 3.52946781 |
| 65 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.52805635 |
| 66 | diterpenoid biosynthetic process (GO:0016102) | 3.52469467 |
| 67 | regulation of water loss via skin (GO:0033561) | 3.51417975 |
| 68 | import into cell (GO:0098657) | 3.48513858 |
| 69 | O-glycan processing (GO:0016266) | 3.47226289 |
| 70 | regulation of lipoprotein metabolic process (GO:0050746) | 3.44993582 |
| 71 | left/right pattern formation (GO:0060972) | 3.42410288 |
| 72 | membrane tubulation (GO:0097320) | 3.40631845 |
| 73 | acyl-CoA biosynthetic process (GO:0071616) | 3.38513001 |
| 74 | thioester biosynthetic process (GO:0035384) | 3.38513001 |
| 75 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.36703649 |
| 76 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.34781748 |
| 77 | phosphate ion homeostasis (GO:0055062) | 3.34303970 |
| 78 | trivalent inorganic anion homeostasis (GO:0072506) | 3.34303970 |
| 79 | protein autoprocessing (GO:0016540) | 3.34043468 |
| 80 | GPI anchor biosynthetic process (GO:0006506) | 3.32158534 |
| 81 | presynaptic membrane organization (GO:0097090) | 3.30942043 |
| 82 | protein palmitoylation (GO:0018345) | 3.30632726 |
| 83 | NADH metabolic process (GO:0006734) | 3.28512018 |
| 84 | sphingomyelin metabolic process (GO:0006684) | 3.26402666 |
| 85 | transcytosis (GO:0045056) | 3.24973435 |
| 86 | digestion (GO:0007586) | 3.24225722 |
| 87 | iron coordination entity transport (GO:1901678) | 3.23426478 |
| 88 | GPI anchor metabolic process (GO:0006505) | 3.23270026 |
| 89 | renal absorption (GO:0070293) | 3.20087282 |
| 90 | lung epithelium development (GO:0060428) | 3.19566461 |
| 91 | negative regulation of humoral immune response (GO:0002921) | 3.15878568 |
| 92 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.14452573 |
| 93 | L-phenylalanine metabolic process (GO:0006558) | 3.14452573 |
| 94 | amyloid precursor protein catabolic process (GO:0042987) | 3.12903299 |
| 95 | glutathione biosynthetic process (GO:0006750) | 3.12801796 |
| 96 | magnesium ion transport (GO:0015693) | 3.12552189 |
| 97 | glycosylceramide metabolic process (GO:0006677) | 3.10375821 |
| 98 | regulation of autophagic vacuole assembly (GO:2000785) | 3.08861220 |
| 99 | primary alcohol metabolic process (GO:0034308) | 3.08643775 |
| 100 | limb bud formation (GO:0060174) | 3.08579684 |
| 101 | negative regulation of cell fate commitment (GO:0010454) | 3.06543068 |
| 102 | neuron remodeling (GO:0016322) | 3.04838424 |
| 103 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.04461793 |
| 104 | protein neddylation (GO:0045116) | 3.04431350 |
| 105 | nucleotide transmembrane transport (GO:1901679) | 3.04086363 |
| 106 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.01918006 |
| 107 | glutathione derivative metabolic process (GO:1901685) | 2.98853162 |
| 108 | glutathione derivative biosynthetic process (GO:1901687) | 2.98853162 |
| 109 | axon development (GO:0061564) | 2.98789601 |
| 110 | negative regulation of axonogenesis (GO:0050771) | 2.98536429 |
| 111 | negative regulation of JUN kinase activity (GO:0043508) | 2.97930684 |
| 112 | positive regulation of pseudopodium assembly (GO:0031274) | 2.96870265 |
| 113 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.96773911 |
| 114 | cellular response to reactive nitrogen species (GO:1902170) | 2.96605566 |
| 115 | excretion (GO:0007588) | 2.95675790 |
| 116 | negative regulation of cell fate specification (GO:0009996) | 2.95273933 |
| 117 | adhesion of symbiont to host (GO:0044406) | 2.94807190 |
| 118 | establishment of monopolar cell polarity (GO:0061162) | 2.93761847 |
| 119 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.93761847 |
| 120 | phosphate ion transmembrane transport (GO:0035435) | 2.93257728 |
| 121 | toxin transport (GO:1901998) | 2.92393915 |
| 122 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.89779253 |
| 123 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.89118152 |
| 124 | presynaptic membrane assembly (GO:0097105) | 2.86952160 |
| 125 | cell-cell junction assembly (GO:0007043) | 2.85537239 |
| 126 | sperm capacitation (GO:0048240) | 2.84561822 |
| 127 | GDP-mannose metabolic process (GO:0019673) | 2.83568541 |
| 128 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.82492561 |
| 129 | response to lead ion (GO:0010288) | 2.82119162 |
| 130 | epoxygenase P450 pathway (GO:0019373) | 2.80368401 |
| 131 | oligosaccharide biosynthetic process (GO:0009312) | 2.79788273 |
| 132 | retinol metabolic process (GO:0042572) | 2.79236296 |
| 133 | establishment of skin barrier (GO:0061436) | 2.78935663 |
| 134 | adult walking behavior (GO:0007628) | 2.78000658 |
| 135 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.76248898 |
| 136 | peripheral nervous system development (GO:0007422) | 2.75586388 |
| 137 | auditory receptor cell differentiation (GO:0042491) | 2.75464291 |
| 138 | proline metabolic process (GO:0006560) | 2.74392161 |
| 139 | prostanoid biosynthetic process (GO:0046457) | 2.73629364 |
| 140 | prostaglandin biosynthetic process (GO:0001516) | 2.73629364 |
| 141 | carnitine metabolic process (GO:0009437) | 2.73465246 |
| 142 | peptide catabolic process (GO:0043171) | 2.73078028 |
| 143 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.72726204 |
| 144 | peptidyl-cysteine modification (GO:0018198) | 2.71596258 |
| 145 | phenol-containing compound catabolic process (GO:0019336) | 2.71411553 |
| 146 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.71255909 |
| 147 | angiotensin maturation (GO:0002003) | 2.71161900 |
| 148 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.68987938 |
| 149 | neural nucleus development (GO:0048857) | 2.67568282 |
| 150 | protein retention in ER lumen (GO:0006621) | 2.65718163 |
| 151 | epithelial cell-cell adhesion (GO:0090136) | 2.65350331 |
| 152 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.64968109 |
| 153 | response to nitric oxide (GO:0071731) | 2.64752887 |
| 154 | peptide biosynthetic process (GO:0043043) | 2.64735055 |
| 155 | Golgi transport vesicle coating (GO:0048200) | 2.64597105 |
| 156 | COPI coating of Golgi vesicle (GO:0048205) | 2.64597105 |
| 157 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.64418741 |
| 158 | regulation of cholesterol metabolic process (GO:0090181) | 2.63954224 |
| 159 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.63443132 |
| 160 | cellular response to epinephrine stimulus (GO:0071872) | 2.63177042 |
| 161 | neurotransmitter biosynthetic process (GO:0042136) | 2.61464755 |
| 162 | hydrogen peroxide catabolic process (GO:0042744) | 2.61380366 |
| 163 | positive regulation of glial cell differentiation (GO:0045687) | 2.60353437 |
| 164 | cholesterol metabolic process (GO:0008203) | 2.59867406 |
| 165 | intestinal absorption (GO:0050892) | 2.59290973 |
| 166 | enteric nervous system development (GO:0048484) | 2.59154673 |
| 167 | negative regulation of axon extension (GO:0030517) | 2.58666778 |
| 168 | ear development (GO:0043583) | 2.58189581 |
| 169 | renal system process involved in regulation of blood volume (GO:0001977) | 2.58070137 |
| 170 | glial cell development (GO:0021782) | 2.57915281 |
| 171 | phosphate ion transport (GO:0006817) | 2.57119324 |
| 172 | amino acid import (GO:0043090) | 2.56831939 |
| 173 | glutathione metabolic process (GO:0006749) | 2.56807286 |
| 174 | organ growth (GO:0035265) | 2.56759838 |
| 175 | negative regulation of acute inflammatory response (GO:0002674) | 2.56665184 |
| 176 | regulation of pseudopodium assembly (GO:0031272) | 2.56222455 |
| 177 | thioester metabolic process (GO:0035383) | 2.55195024 |
| 178 | acyl-CoA metabolic process (GO:0006637) | 2.55195024 |
| 179 | vitamin transport (GO:0051180) | 2.54826734 |
| 180 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.54596491 |
| 181 | positive regulation of action potential (GO:0045760) | 2.52195196 |
| 182 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.51604320 |
| 183 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.51329339 |
| 184 | gap junction assembly (GO:0016264) | 2.50861007 |
| 185 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.50124780 |
| 186 | L-ascorbic acid metabolic process (GO:0019852) | 2.48853109 |
| 187 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.47354295 |
| 188 | central nervous system myelination (GO:0022010) | 12.0041662 |
| 189 | axon ensheathment in central nervous system (GO:0032291) | 12.0041662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.14687349 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.65763444 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.51144114 |
| 4 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.06931023 |
| 5 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.91490666 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.84885017 |
| 7 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.74593763 |
| 8 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.67262922 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.62175662 |
| 10 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.59212459 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.57870843 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.31495043 |
| 13 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 2.19320497 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.12147236 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.07168351 |
| 16 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.01103069 |
| 17 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.96557263 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.95987363 |
| 19 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.94906015 |
| 20 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.94841894 |
| 21 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.90662679 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88347883 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.87451586 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87290216 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82624106 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.80240360 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79363292 |
| 28 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.77509776 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76711798 |
| 30 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.75229783 |
| 31 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.74181538 |
| 32 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.74113350 |
| 33 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.73589145 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72385199 |
| 35 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.70532835 |
| 36 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.69046296 |
| 37 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68721577 |
| 38 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.68039534 |
| 39 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.66780080 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66335738 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65187413 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65187413 |
| 43 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.65011470 |
| 44 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.64571897 |
| 45 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.63991983 |
| 46 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63229690 |
| 47 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.61386876 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61371648 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60427006 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60024915 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.59476730 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.56409180 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56408076 |
| 54 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.55609119 |
| 55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.54936160 |
| 56 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.50867742 |
| 57 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50360664 |
| 58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.49289581 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.47395605 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.44142964 |
| 61 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.43171857 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.36484539 |
| 63 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34461769 |
| 64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31480003 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31191634 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30873508 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30601917 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30569587 |
| 69 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.29790121 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29494263 |
| 71 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28706291 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28345504 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28345504 |
| 74 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.26805343 |
| 75 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.26719233 |
| 76 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26480264 |
| 77 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26368781 |
| 78 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.25277198 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24295223 |
| 80 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23767219 |
| 81 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.22947531 |
| 82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22282439 |
| 83 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20494569 |
| 84 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.18850972 |
| 85 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17820076 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17394013 |
| 87 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.17266373 |
| 88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17010992 |
| 89 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.16441600 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.16112590 |
| 91 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.15317958 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14734589 |
| 93 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14094263 |
| 94 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13908746 |
| 95 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12833545 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12213846 |
| 97 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10735577 |
| 98 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09644723 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08360142 |
| 100 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.08078959 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07852178 |
| 102 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07739949 |
| 103 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07604670 |
| 104 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.07160205 |
| 105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06351938 |
| 106 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06054781 |
| 107 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.05328571 |
| 108 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04538322 |
| 109 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.04277780 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03929301 |
| 111 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03898235 |
| 112 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.03311652 |
| 113 | P68_20966046_ChIP-Seq_HELA_Human | 1.02680729 |
| 114 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02599738 |
| 115 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02526950 |
| 116 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02075314 |
| 117 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01743265 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01676202 |
| 119 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01260483 |
| 120 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01046497 |
| 121 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00555841 |
| 122 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00330095 |
| 123 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99304132 |
| 124 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98827644 |
| 125 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98707073 |
| 126 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98450515 |
| 127 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98450515 |
| 128 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97746539 |
| 129 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.97708794 |
| 130 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96590659 |
| 131 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95513412 |
| 132 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95113028 |
| 133 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94613991 |
| 134 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93937390 |
| 135 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.93629098 |
| 136 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.93123152 |
| 137 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93061446 |
| 138 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91910649 |
| 139 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.91837250 |
| 140 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.91270635 |
| 141 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91150836 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90612822 |
| 143 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.89757303 |
| 144 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89519210 |
| 145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88770214 |
| 146 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87685645 |
| 147 | FUS_26573619_Chip-Seq_HEK293_Human | 0.87559592 |
| 148 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.87410594 |
| 149 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.86875717 |
| 150 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86772305 |
| 151 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86679760 |
| 152 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86399192 |
| 153 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86399192 |
| 154 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85806526 |
| 155 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85151945 |
| 156 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84694326 |
| 157 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.84579145 |
| 158 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.84480061 |
| 159 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.84249844 |
| 160 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83787297 |
| 161 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83732430 |
| 162 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.83045250 |
| 163 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.82973816 |
| 164 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82557121 |
| 165 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82406017 |
| 166 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.81948344 |
| 167 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81749921 |
| 168 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81190213 |
| 169 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.81122359 |
| 170 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.81122359 |
| 171 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.81122359 |
| 172 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81030267 |
| 173 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.80655048 |
| 174 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80624577 |
| 175 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80200037 |
| 176 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.79883794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 6.22174629 |
| 2 | MP0000920_abnormal_myelination | 5.86711342 |
| 3 | MP0004782_abnormal_surfactant_physiolog | 5.27703641 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.68637662 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.57692134 |
| 6 | MP0003880_abnormal_central_pattern | 3.51597589 |
| 7 | MP0003690_abnormal_glial_cell | 3.34691648 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.99502838 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 2.87497883 |
| 10 | MP0004270_analgesia | 2.86994609 |
| 11 | MP0003329_amyloid_beta_deposits | 2.86057880 |
| 12 | MP0004885_abnormal_endolymph | 2.80109193 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.76330394 |
| 14 | MP0001529_abnormal_vocalization | 2.55393121 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.47123502 |
| 16 | MP0005171_absent_coat_pigmentation | 2.44563365 |
| 17 | MP0004742_abnormal_vestibular_system | 2.42195523 |
| 18 | MP0003634_abnormal_glial_cell | 2.37426734 |
| 19 | MP0010678_abnormal_skin_adnexa | 2.25922918 |
| 20 | MP0005451_abnormal_body_composition | 2.23781337 |
| 21 | MP0005365_abnormal_bile_salt | 2.22458457 |
| 22 | MP0002098_abnormal_vibrissa_morphology | 2.22079815 |
| 23 | MP0000383_abnormal_hair_follicle | 2.21889749 |
| 24 | MP0001905_abnormal_dopamine_level | 2.21344039 |
| 25 | MP0002272_abnormal_nervous_system | 2.18496904 |
| 26 | MP0004381_abnormal_hair_follicle | 2.14444131 |
| 27 | MP0003136_yellow_coat_color | 2.14206751 |
| 28 | MP0001485_abnormal_pinna_reflex | 2.11404713 |
| 29 | MP0009379_abnormal_foot_pigmentation | 2.09765348 |
| 30 | MP0004142_abnormal_muscle_tone | 2.09373988 |
| 31 | MP0003195_calcinosis | 2.07438681 |
| 32 | MP0000462_abnormal_digestive_system | 2.07154810 |
| 33 | MP0001486_abnormal_startle_reflex | 2.05503151 |
| 34 | MP0000678_abnormal_parathyroid_gland | 1.96137224 |
| 35 | MP0004043_abnormal_pH_regulation | 1.93707603 |
| 36 | MP0003632_abnormal_nervous_system | 1.92347591 |
| 37 | MP0002229_neurodegeneration | 1.85941862 |
| 38 | MP0000778_abnormal_nervous_system | 1.84036723 |
| 39 | MP0001765_abnormal_ion_homeostasis | 1.80651184 |
| 40 | MP0001958_emphysema | 1.80180404 |
| 41 | MP0005409_darkened_coat_color | 1.79635122 |
| 42 | MP0002064_seizures | 1.77551922 |
| 43 | MP0002909_abnormal_adrenal_gland | 1.76528557 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.76068493 |
| 45 | MP0005410_abnormal_fertilization | 1.74934063 |
| 46 | MP0005377_hearing/vestibular/ear_phenot | 1.74266757 |
| 47 | MP0003878_abnormal_ear_physiology | 1.74266757 |
| 48 | MP0001664_abnormal_digestion | 1.71140036 |
| 49 | MP0008260_abnormal_autophagy | 1.69926752 |
| 50 | MP0000604_amyloidosis | 1.59525878 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.57061352 |
| 52 | MP0003879_abnormal_hair_cell | 1.55240508 |
| 53 | MP0009840_abnormal_foam_cell | 1.54341590 |
| 54 | MP0000566_synostosis | 1.49923399 |
| 55 | MP0005501_abnormal_skin_physiology | 1.46827948 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 1.43566170 |
| 57 | MP0004858_abnormal_nervous_system | 1.42729201 |
| 58 | MP0008004_abnormal_stomach_pH | 1.42101304 |
| 59 | MP0001756_abnormal_urination | 1.41084644 |
| 60 | MP0002653_abnormal_ependyma_morphology | 1.39282435 |
| 61 | MP0004147_increased_porphyrin_level | 1.39151014 |
| 62 | MP0008995_early_reproductive_senescence | 1.38830268 |
| 63 | MP0003941_abnormal_skin_development | 1.37707299 |
| 64 | MP0003631_nervous_system_phenotype | 1.37302998 |
| 65 | MP0005423_abnormal_somatic_nervous | 1.35499944 |
| 66 | MP0000647_abnormal_sebaceous_gland | 1.34294074 |
| 67 | MP0001346_abnormal_lacrimal_gland | 1.34203759 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.33251273 |
| 69 | MP0002254_reproductive_system_inflammat | 1.31387160 |
| 70 | MP0001881_abnormal_mammary_gland | 1.29986643 |
| 71 | MP0005408_hypopigmentation | 1.29456790 |
| 72 | MP0005551_abnormal_eye_electrophysiolog | 1.28038809 |
| 73 | MP0004134_abnormal_chest_morphology | 1.25200840 |
| 74 | MP0002876_abnormal_thyroid_physiology | 1.24189103 |
| 75 | MP0000747_muscle_weakness | 1.22327198 |
| 76 | MP0000579_abnormal_nail_morphology | 1.19766195 |
| 77 | MP0009745_abnormal_behavioral_response | 1.19495066 |
| 78 | MP0000955_abnormal_spinal_cord | 1.19197758 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 1.17718210 |
| 80 | MP0002132_abnormal_respiratory_system | 1.17042375 |
| 81 | MP0003866_abnormal_defecation | 1.15908409 |
| 82 | MP0009046_muscle_twitch | 1.15490715 |
| 83 | MP0000762_abnormal_tongue_morphology | 1.14695524 |
| 84 | MP0004859_abnormal_synaptic_plasticity | 1.14577410 |
| 85 | MP0002882_abnormal_neuron_morphology | 1.13752384 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 1.12229456 |
| 87 | MP0010155_abnormal_intestine_physiology | 1.11864199 |
| 88 | MP0000627_abnormal_mammary_gland | 1.10458154 |
| 89 | MP0003633_abnormal_nervous_system | 1.09586765 |
| 90 | MP0000377_abnormal_hair_follicle | 1.09248277 |
| 91 | MP0001661_extended_life_span | 1.07676531 |
| 92 | MP0005083_abnormal_biliary_tract | 1.07292211 |
| 93 | MP0001666_abnormal_nutrient_absorption | 1.07076140 |
| 94 | MP0005220_abnormal_exocrine_pancreas | 1.05605439 |
| 95 | MP0002295_abnormal_pulmonary_circulatio | 1.05439057 |
| 96 | MP0002066_abnormal_motor_capabilities/c | 1.05347344 |
| 97 | MP0001963_abnormal_hearing_physiology | 1.03679636 |
| 98 | MP0001440_abnormal_grooming_behavior | 1.03604211 |
| 99 | MP0001851_eye_inflammation | 1.01781868 |
| 100 | MP0005360_urolithiasis | 1.01132674 |
| 101 | MP0000477_abnormal_intestine_morphology | 1.00600777 |
| 102 | MP0003635_abnormal_synaptic_transmissio | 0.99570928 |
| 103 | MP0002752_abnormal_somatic_nervous | 0.99210428 |
| 104 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98847132 |
| 105 | MP0002796_impaired_skin_barrier | 0.97999674 |
| 106 | MP0001944_abnormal_pancreas_morphology | 0.97546903 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.97385215 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.97320073 |
| 109 | MP0000467_abnormal_esophagus_morphology | 0.96364654 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.94563074 |
| 111 | MP0000537_abnormal_urethra_morphology | 0.94043398 |
| 112 | MP0005332_abnormal_amino_acid | 0.93333951 |
| 113 | MP0008569_lethality_at_weaning | 0.92929333 |
| 114 | MP0005195_abnormal_posterior_eye | 0.92869552 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.90925673 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.90861431 |
| 117 | MP0005166_decreased_susceptibility_to | 0.89818313 |
| 118 | MP0006082_CNS_inflammation | 0.89782338 |
| 119 | MP0002139_abnormal_hepatobiliary_system | 0.88846307 |
| 120 | MP0001727_abnormal_embryo_implantation | 0.87661776 |
| 121 | MP0002572_abnormal_emotion/affect_behav | 0.86984126 |
| 122 | MP0002168_other_aberrant_phenotype | 0.86193483 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.85438260 |
| 124 | MP0004924_abnormal_behavior | 0.85293855 |
| 125 | MP0005386_behavior/neurological_phenoty | 0.85293855 |
| 126 | MP0001873_stomach_inflammation | 0.85264445 |
| 127 | MP0002118_abnormal_lipid_homeostasis | 0.84790127 |
| 128 | MP0010771_integument_phenotype | 0.84196829 |
| 129 | MP0001970_abnormal_pain_threshold | 0.83817340 |
| 130 | MP0003937_abnormal_limbs/digits/tail_de | 0.83488769 |
| 131 | MP0003938_abnormal_ear_development | 0.82720782 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.81989375 |
| 133 | MP0005165_increased_susceptibility_to | 0.81832848 |
| 134 | MP0002822_catalepsy | 0.81631221 |
| 135 | MP0001849_ear_inflammation | 0.81329880 |
| 136 | MP0003183_abnormal_peptide_metabolism | 0.81195142 |
| 137 | MP0005388_respiratory_system_phenotype | 0.80095038 |
| 138 | MP0002133_abnormal_respiratory_system | 0.80095038 |
| 139 | MP0001177_atelectasis | 0.78981059 |
| 140 | MP0005623_abnormal_meninges_morphology | 0.78816098 |
| 141 | MP0004185_abnormal_adipocyte_glucose | 0.78341011 |
| 142 | MP0000538_abnormal_urinary_bladder | 0.77255817 |
| 143 | MP0005395_other_phenotype | 0.75811250 |
| 144 | MP0003075_altered_response_to | 0.74987724 |
| 145 | MP0005381_digestive/alimentary_phenotyp | 0.73931859 |
| 146 | MP0002067_abnormal_sensory_capabilities | 0.73391486 |
| 147 | MP0005085_abnormal_gallbladder_physiolo | 0.72804575 |
| 148 | MP0005645_abnormal_hypothalamus_physiol | 0.70387773 |
| 149 | MP0002063_abnormal_learning/memory/cond | 0.69702062 |
| 150 | MP0002249_abnormal_larynx_morphology | 0.69385023 |
| 151 | MP0003953_abnormal_hormone_level | 0.69133618 |
| 152 | MP0000470_abnormal_stomach_morphology | 0.67361360 |
| 153 | MP0003453_abnormal_keratinocyte_physiol | 0.67051654 |
| 154 | MP0008438_abnormal_cutaneous_collagen | 0.66708694 |
| 155 | MP0003123_paternal_imprinting | 0.66389219 |
| 156 | MP0000026_abnormal_inner_ear | 0.66371838 |
| 157 | MP0005023_abnormal_wound_healing | 0.66008611 |
| 158 | MP0005076_abnormal_cell_differentiation | 0.64096888 |
| 159 | MP0001663_abnormal_digestive_system | 0.63367456 |
| 160 | MP0003045_fibrosis | 0.62969687 |
| 161 | MP0001340_abnormal_eyelid_morphology | 0.62322670 |
| 162 | MP0002733_abnormal_thermal_nociception | 0.61225001 |
| 163 | MP0002138_abnormal_hepatobiliary_system | 0.61132929 |
| 164 | MP0000003_abnormal_adipose_tissue | 0.60820921 |
| 165 | MP0003656_abnormal_erythrocyte_physiolo | 0.60711262 |
| 166 | MP0001984_abnormal_olfaction | 0.60337462 |
| 167 | MP0002152_abnormal_brain_morphology | 0.59527237 |
| 168 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58493884 |
| 169 | MP0004133_heterotaxia | 0.57524356 |
| 170 | MP0000613_abnormal_salivary_gland | 0.55919032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 7.80583673 |
| 2 | Chronic bronchitis (HP:0004469) | 7.00496836 |
| 3 | Rhinitis (HP:0012384) | 6.94768865 |
| 4 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.90905998 |
| 5 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.90905998 |
| 6 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.82731451 |
| 7 | Abnormal ciliary motility (HP:0012262) | 6.56259346 |
| 8 | Neurofibrillary tangles (HP:0002185) | 5.93423961 |
| 9 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.90757837 |
| 10 | Absent/shortened dynein arms (HP:0200106) | 5.90757837 |
| 11 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.86470821 |
| 12 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.86470821 |
| 13 | Hyperactive renin-angiotensin system (HP:0000841) | 5.86451565 |
| 14 | Interstitial pulmonary disease (HP:0006530) | 5.54674454 |
| 15 | Parakeratosis (HP:0001036) | 5.50390604 |
| 16 | Bronchiectasis (HP:0002110) | 5.24372472 |
| 17 | Sensory axonal neuropathy (HP:0003390) | 5.19005031 |
| 18 | Peripheral hypomyelination (HP:0007182) | 4.55890280 |
| 19 | Nasal polyposis (HP:0100582) | 4.52093799 |
| 20 | Cerebral hypomyelination (HP:0006808) | 4.49317016 |
| 21 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.34824924 |
| 22 | Abnormality of the corticospinal tract (HP:0002492) | 4.33549590 |
| 23 | Cerebral inclusion bodies (HP:0100314) | 4.23151054 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.99662773 |
| 25 | Onion bulb formation (HP:0003383) | 3.72209396 |
| 26 | Renal salt wasting (HP:0000127) | 3.65293634 |
| 27 | Decreased circulating renin level (HP:0003351) | 3.59455260 |
| 28 | Abnormal auditory evoked potentials (HP:0006958) | 3.50063556 |
| 29 | Abnormality of renin-angiotensin system (HP:0000847) | 3.46095299 |
| 30 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.44670067 |
| 31 | Leukodystrophy (HP:0002415) | 3.38672165 |
| 32 | Abnormality of glycolysis (HP:0004366) | 3.36791308 |
| 33 | Increased serum pyruvate (HP:0003542) | 3.36791308 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.28574993 |
| 35 | Intention tremor (HP:0002080) | 3.28350113 |
| 36 | Supranuclear gaze palsy (HP:0000605) | 3.26426417 |
| 37 | Alacrima (HP:0000522) | 3.24139338 |
| 38 | Pili torti (HP:0003777) | 3.20863397 |
| 39 | Spastic paraparesis (HP:0002313) | 3.18631719 |
| 40 | Spastic gait (HP:0002064) | 3.11242066 |
| 41 | Bronchitis (HP:0012387) | 3.10089500 |
| 42 | Infertility (HP:0000789) | 3.05888075 |
| 43 | Hyperaldosteronism (HP:0000859) | 3.00875333 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.99566972 |
| 45 | Dysmetria (HP:0001310) | 2.86361735 |
| 46 | CNS hypomyelination (HP:0003429) | 2.85174484 |
| 47 | Male infertility (HP:0003251) | 2.78644734 |
| 48 | Abnormality of chloride homeostasis (HP:0011422) | 2.77906047 |
| 49 | Termporal pattern (HP:0011008) | 2.76762841 |
| 50 | Insidious onset (HP:0003587) | 2.76762841 |
| 51 | Right ventricular cardiomyopathy (HP:0011663) | 2.76686976 |
| 52 | Tubulointerstitial fibrosis (HP:0005576) | 2.76390432 |
| 53 | Hyperphosphatemia (HP:0002905) | 2.76191783 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.73865358 |
| 55 | Abnormality of proline metabolism (HP:0010907) | 2.73865358 |
| 56 | Gout (HP:0001997) | 2.72958653 |
| 57 | Slow saccadic eye movements (HP:0000514) | 2.67096928 |
| 58 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.66998440 |
| 59 | Malnutrition (HP:0004395) | 2.66496859 |
| 60 | Premature skin wrinkling (HP:0100678) | 2.63534474 |
| 61 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.61882511 |
| 62 | Hypoplastic pelvis (HP:0008839) | 2.60231886 |
| 63 | Increased circulating renin level (HP:0000848) | 2.60214239 |
| 64 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.58046306 |
| 65 | Anteriorly placed anus (HP:0001545) | 2.56321457 |
| 66 | Stridor (HP:0010307) | 2.55416678 |
| 67 | Chronic sinusitis (HP:0011109) | 2.53744958 |
| 68 | Scanning speech (HP:0002168) | 2.51924076 |
| 69 | Decreased lacrimation (HP:0000633) | 2.51214751 |
| 70 | Vascular calcification (HP:0004934) | 2.45366413 |
| 71 | Fat malabsorption (HP:0002630) | 2.45169285 |
| 72 | Renal Fanconi syndrome (HP:0001994) | 2.44928022 |
| 73 | Ileus (HP:0002595) | 2.43136515 |
| 74 | Cerebral hemorrhage (HP:0001342) | 2.42876017 |
| 75 | Atelectasis (HP:0100750) | 2.42246251 |
| 76 | Hyperkalemia (HP:0002153) | 2.42168111 |
| 77 | Akinesia (HP:0002304) | 2.41098278 |
| 78 | Ankle clonus (HP:0011448) | 2.41016930 |
| 79 | Flat acetabular roof (HP:0003180) | 2.39378610 |
| 80 | Thickened helices (HP:0000391) | 2.37014121 |
| 81 | Morphological abnormality of the inner ear (HP:0011390) | 2.35947918 |
| 82 | Metabolic alkalosis (HP:0200114) | 2.35119610 |
| 83 | Methylmalonic acidemia (HP:0002912) | 2.34055100 |
| 84 | Myokymia (HP:0002411) | 2.32900659 |
| 85 | Clumsiness (HP:0002312) | 2.32630355 |
| 86 | Split foot (HP:0001839) | 2.32534625 |
| 87 | Erythroderma (HP:0001019) | 2.32475852 |
| 88 | Hyponatremia (HP:0002902) | 2.31112398 |
| 89 | Steatorrhea (HP:0002570) | 2.30847450 |
| 90 | Hypomagnesemia (HP:0002917) | 2.30452158 |
| 91 | Intrahepatic cholestasis (HP:0001406) | 2.30233772 |
| 92 | Paraparesis (HP:0002385) | 2.27725657 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.27047701 |
| 94 | Infantile muscular hypotonia (HP:0008947) | 2.26398248 |
| 95 | Amelogenesis imperfecta (HP:0000705) | 2.25766590 |
| 96 | Axonal loss (HP:0003447) | 2.24436410 |
| 97 | Abnormal hair laboratory examination (HP:0003328) | 2.23814613 |
| 98 | Distal lower limb muscle weakness (HP:0009053) | 2.23406668 |
| 99 | Abnormality of permanent molar morphology (HP:0011071) | 2.22081506 |
| 100 | Abnormality of the dental root (HP:0006486) | 2.22081506 |
| 101 | Taurodontia (HP:0000679) | 2.22081506 |
| 102 | Patchy hypopigmentation of hair (HP:0011365) | 2.21353492 |
| 103 | White forelock (HP:0002211) | 2.20514048 |
| 104 | Absent septum pellucidum (HP:0001331) | 2.19666887 |
| 105 | Hypokalemic alkalosis (HP:0001949) | 2.19272803 |
| 106 | Recurrent otitis media (HP:0000403) | 2.19148701 |
| 107 | Retinal dysplasia (HP:0007973) | 2.18966322 |
| 108 | Spastic tetraparesis (HP:0001285) | 2.17446107 |
| 109 | Acute encephalopathy (HP:0006846) | 2.15202743 |
| 110 | Autoamputation (HP:0001218) | 2.12890464 |
| 111 | Acute necrotizing encephalopathy (HP:0006965) | 2.12643692 |
| 112 | Bell-shaped thorax (HP:0001591) | 2.11840419 |
| 113 | Recurrent sinusitis (HP:0011108) | 2.09827930 |
| 114 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.09509602 |
| 115 | Tachypnea (HP:0002789) | 2.09338426 |
| 116 | Hypophosphatemic rickets (HP:0004912) | 2.07501762 |
| 117 | Hypoplasia of the iris (HP:0007676) | 2.06102064 |
| 118 | Coronal craniosynostosis (HP:0004440) | 2.06097978 |
| 119 | Respiratory distress (HP:0002098) | 2.05107899 |
| 120 | Hyperlipoproteinemia (HP:0010980) | 2.02774603 |
| 121 | Hypotension (HP:0002615) | 2.02177192 |
| 122 | Abnormality of the dental pulp (HP:0006479) | 2.01524608 |
| 123 | Esophageal atresia (HP:0002032) | 2.01091296 |
| 124 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.00046202 |
| 125 | Alkalosis (HP:0001948) | 1.99957039 |
| 126 | Abnormality of molar (HP:0011077) | 1.99615685 |
| 127 | Abnormality of molar morphology (HP:0011070) | 1.99615685 |
| 128 | Partial duplication of thumb phalanx (HP:0009944) | 1.99209234 |
| 129 | Growth hormone excess (HP:0000845) | 1.96550449 |
| 130 | Hypokinesia (HP:0002375) | 1.96134132 |
| 131 | Cardiovascular calcification (HP:0011915) | 1.95511203 |
| 132 | Abnormality of vitamin metabolism (HP:0100508) | 1.95452126 |
| 133 | Hyperglycinuria (HP:0003108) | 1.94924216 |
| 134 | Villous atrophy (HP:0011473) | 1.94714455 |
| 135 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.94714455 |
| 136 | Abdominal distention (HP:0003270) | 1.94074996 |
| 137 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.93991084 |
| 138 | Peripheral demyelination (HP:0011096) | 1.93752738 |
| 139 | Spinal cord compression (HP:0002176) | 1.93237115 |
| 140 | Pheochromocytoma (HP:0002666) | 1.91163905 |
| 141 | Muscle fiber splitting (HP:0003555) | 1.90289604 |
| 142 | Foot dorsiflexor weakness (HP:0009027) | 1.89662773 |
| 143 | Chronic otitis media (HP:0000389) | 1.89409142 |
| 144 | Bronchomalacia (HP:0002780) | 1.87918727 |
| 145 | Abnormality of sodium homeostasis (HP:0010931) | 1.87862975 |
| 146 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.87735440 |
| 147 | Aplasia of the phalanges of the hand (HP:0009802) | 1.87735440 |
| 148 | Aplasia involving bones of the extremities (HP:0009825) | 1.87735440 |
| 149 | Choreoathetosis (HP:0001266) | 1.87233560 |
| 150 | Abnormality of the septum pellucidum (HP:0007375) | 1.85991173 |
| 151 | Poor speech (HP:0002465) | 1.83543871 |
| 152 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80100050 |
| 153 | Synostosis involving the elbow (HP:0003938) | 1.80052682 |
| 154 | Humeroradial synostosis (HP:0003041) | 1.80052682 |
| 155 | Megalencephaly (HP:0001355) | 1.79895256 |
| 156 | Adrenal overactivity (HP:0002717) | 1.79214486 |
| 157 | Abnormality of magnesium homeostasis (HP:0004921) | 1.78205011 |
| 158 | Prolonged neonatal jaundice (HP:0006579) | 1.77774997 |
| 159 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77189326 |
| 160 | Cupped ear (HP:0000378) | 1.77085727 |
| 161 | Hyporeflexia of lower limbs (HP:0002600) | 1.76949112 |
| 162 | Mitochondrial inheritance (HP:0001427) | 1.76921054 |
| 163 | Bifid scrotum (HP:0000048) | 1.76645925 |
| 164 | Abnormality of the salivary glands (HP:0010286) | 1.76331009 |
| 165 | Decreased motor nerve conduction velocity (HP:0003431) | 1.73850300 |
| 166 | Hepatocellular necrosis (HP:0001404) | 1.73724619 |
| 167 | Stenosis of the external auditory canal (HP:0000402) | 1.72906728 |
| 168 | Hyperparathyroidism (HP:0000843) | 1.72735241 |
| 169 | Hyperuricemia (HP:0002149) | 1.71301852 |
| 170 | Increased purine levels (HP:0004368) | 1.71301852 |
| 171 | Bowel incontinence (HP:0002607) | 1.71011498 |
| 172 | Tubulointerstitial abnormality (HP:0001969) | 1.70996973 |
| 173 | Cystic liver disease (HP:0006706) | 1.69697730 |
| 174 | Clonus (HP:0002169) | 1.69297777 |
| 175 | Abnormality of the foot musculature (HP:0001436) | 1.68627082 |
| 176 | Partial agenesis of the corpus callosum (HP:0001338) | 1.68547380 |
| 177 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.68235328 |
| 178 | Tubular atrophy (HP:0000092) | 1.67834971 |
| 179 | Tubulointerstitial nephritis (HP:0001970) | 1.67506882 |
| 180 | Germ cell neoplasia (HP:0100728) | 1.63237316 |
| 181 | Abnormality of renal excretion (HP:0011036) | 1.62035844 |
| 182 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.61679007 |
| 183 | Abnormality of glycine metabolism (HP:0010895) | 1.61679007 |
| 184 | Popliteal pterygium (HP:0009756) | 1.59471000 |
| 185 | Goiter (HP:0000853) | 1.57666483 |
| 186 | Occipital encephalocele (HP:0002085) | 1.57581379 |
| 187 | Short nail (HP:0001799) | 1.57126732 |
| 188 | Ventricular fibrillation (HP:0001663) | 1.56851781 |
| 189 | Hyperthyroidism (HP:0000836) | 1.56725478 |
| 190 | Glomerulosclerosis (HP:0000096) | 1.55966143 |
| 191 | Glucose intolerance (HP:0000833) | 1.55662414 |
| 192 | Hypoglycemic seizures (HP:0002173) | 1.55586159 |
| 193 | Abnormal glucose tolerance (HP:0001952) | 1.51719491 |
| 194 | Symptomatic seizures (HP:0011145) | 1.49790871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.47428622 |
| 2 | OXSR1 | 4.82163712 |
| 3 | EPHB1 | 3.71811206 |
| 4 | MST1R | 3.60952213 |
| 5 | BCR | 3.24560174 |
| 6 | MET | 2.82477375 |
| 7 | PKN1 | 2.80658898 |
| 8 | WNK4 | 2.75832181 |
| 9 | SMG1 | 2.62387204 |
| 10 | CDK19 | 2.58156363 |
| 11 | PBK | 2.53038420 |
| 12 | TRIB3 | 2.48928280 |
| 13 | FGFR2 | 2.34386539 |
| 14 | MAPKAPK5 | 2.28938391 |
| 15 | LMTK2 | 2.28382059 |
| 16 | TESK1 | 2.24677549 |
| 17 | CSNK1G3 | 2.15230810 |
| 18 | MAPKAPK3 | 2.14811501 |
| 19 | CSNK1A1L | 2.07943896 |
| 20 | LIMK1 | 2.04166966 |
| 21 | TESK2 | 2.01017618 |
| 22 | RIPK1 | 1.94305006 |
| 23 | FER | 1.91762050 |
| 24 | SIK1 | 1.91605640 |
| 25 | MAP3K12 | 1.86187332 |
| 26 | NEK6 | 1.73976045 |
| 27 | PAK4 | 1.71767091 |
| 28 | CSNK1G1 | 1.69080912 |
| 29 | WNK1 | 1.68341361 |
| 30 | TNIK | 1.66411473 |
| 31 | PRPF4B | 1.64385159 |
| 32 | UHMK1 | 1.64135449 |
| 33 | CAMK2B | 1.63712760 |
| 34 | RPS6KB2 | 1.61643811 |
| 35 | STK24 | 1.61421793 |
| 36 | MST4 | 1.57805871 |
| 37 | CSNK1G2 | 1.56383407 |
| 38 | ROCK2 | 1.50520538 |
| 39 | STK38 | 1.48311421 |
| 40 | ICK | 1.39717952 |
| 41 | CAMK2D | 1.39498151 |
| 42 | LATS2 | 1.38218806 |
| 43 | MAP3K3 | 1.37300301 |
| 44 | NTRK1 | 1.36588512 |
| 45 | PNCK | 1.34543574 |
| 46 | FGR | 1.31312785 |
| 47 | PTK6 | 1.26497031 |
| 48 | FGFR4 | 1.24118463 |
| 49 | PRKCI | 1.22065797 |
| 50 | CLK1 | 1.20598644 |
| 51 | ERN1 | 1.18606692 |
| 52 | PRKG2 | 1.18182788 |
| 53 | LRRK2 | 1.16626396 |
| 54 | SGK223 | 1.16553237 |
| 55 | SGK494 | 1.16553237 |
| 56 | PRKD3 | 1.16552783 |
| 57 | EPHA3 | 1.13791952 |
| 58 | CAMK2G | 1.13271029 |
| 59 | EEF2K | 1.12238439 |
| 60 | TAOK1 | 1.09097484 |
| 61 | STK38L | 1.05892283 |
| 62 | PAK6 | 1.05312255 |
| 63 | DYRK2 | 1.04541633 |
| 64 | MAPK15 | 1.03124866 |
| 65 | TYRO3 | 1.02886131 |
| 66 | EIF2AK1 | 0.99448735 |
| 67 | CASK | 0.95677874 |
| 68 | ILK | 0.93697823 |
| 69 | EPHA4 | 0.87884078 |
| 70 | ERBB4 | 0.85372232 |
| 71 | MYLK | 0.84388126 |
| 72 | PTK2 | 0.84252609 |
| 73 | PRKCQ | 0.81430428 |
| 74 | CDK14 | 0.81132997 |
| 75 | TTK | 0.80841155 |
| 76 | PRKD1 | 0.78862472 |
| 77 | TRPM7 | 0.78292516 |
| 78 | MAP2K2 | 0.77705314 |
| 79 | NLK | 0.74061744 |
| 80 | CAMK2A | 0.73641072 |
| 81 | MARK2 | 0.73502620 |
| 82 | MARK1 | 0.72729030 |
| 83 | ARAF | 0.69335165 |
| 84 | PDPK1 | 0.68695924 |
| 85 | CDK5 | 0.67396428 |
| 86 | PAK3 | 0.67274344 |
| 87 | CDK15 | 0.67129883 |
| 88 | IRAK3 | 0.64128899 |
| 89 | PRKCE | 0.63082809 |
| 90 | MAP2K6 | 0.62032078 |
| 91 | SCYL2 | 0.61264778 |
| 92 | CDK18 | 0.61070556 |
| 93 | RPS6KA2 | 0.60856377 |
| 94 | IRAK2 | 0.60662305 |
| 95 | CDK11A | 0.60301389 |
| 96 | ERBB2 | 0.58745396 |
| 97 | LATS1 | 0.58354160 |
| 98 | FGFR3 | 0.58290450 |
| 99 | MAP3K1 | 0.57709409 |
| 100 | MELK | 0.55301632 |
| 101 | FYN | 0.53901318 |
| 102 | ACVR1B | 0.53876890 |
| 103 | BMPR1B | 0.53329222 |
| 104 | TBK1 | 0.52591232 |
| 105 | GSK3A | 0.52439598 |
| 106 | PKN2 | 0.52298771 |
| 107 | HIPK2 | 0.51048938 |
| 108 | RPS6KA5 | 0.50263366 |
| 109 | BCKDK | 0.49081418 |
| 110 | CSNK1D | 0.47054614 |
| 111 | DAPK1 | 0.46728783 |
| 112 | PHKG1 | 0.45226208 |
| 113 | PHKG2 | 0.45226208 |
| 114 | CSNK1A1 | 0.45179870 |
| 115 | DMPK | 0.44319422 |
| 116 | EPHA2 | 0.43551185 |
| 117 | DAPK2 | 0.42502281 |
| 118 | YES1 | 0.42488758 |
| 119 | CDC42BPA | 0.42036374 |
| 120 | PAK1 | 0.41505295 |
| 121 | PRKG1 | 0.41335105 |
| 122 | PRKACB | 0.41036854 |
| 123 | MUSK | 0.39650334 |
| 124 | PRKCZ | 0.37817460 |
| 125 | STK11 | 0.37015115 |
| 126 | GRK7 | 0.36513097 |
| 127 | NME2 | 0.35727842 |
| 128 | DAPK3 | 0.35287981 |
| 129 | PIK3CA | 0.34684649 |
| 130 | MAP3K2 | 0.32821078 |
| 131 | PINK1 | 0.32262291 |
| 132 | PRKD2 | 0.32094795 |
| 133 | IRAK1 | 0.32082422 |
| 134 | PRKCA | 0.31318262 |
| 135 | NME1 | 0.31251771 |
| 136 | STK16 | 0.29434031 |
| 137 | MAP3K8 | 0.29284864 |
| 138 | PRKCD | 0.29064513 |
| 139 | KSR2 | 0.28988890 |
| 140 | PDGFRB | 0.28152802 |
| 141 | GRK1 | 0.28118238 |
| 142 | MAPK7 | 0.27890703 |
| 143 | PRKCH | 0.27747377 |
| 144 | PDK1 | 0.27417899 |
| 145 | ADRBK2 | 0.26390353 |
| 146 | SRC | 0.26045841 |
| 147 | CSNK1E | 0.25882317 |
| 148 | PRKACA | 0.25469357 |
| 149 | NTRK3 | 0.25200818 |
| 150 | OBSCN | 0.25161660 |
| 151 | ITK | 0.25126172 |
| 152 | ABL2 | 0.25066167 |
| 153 | TIE1 | 0.24356994 |
| 154 | INSR | 0.23297169 |
| 155 | PRKAA2 | 0.22661349 |
| 156 | BMX | 0.22150486 |
| 157 | MAPK13 | 0.21956540 |
| 158 | ALK | 0.20397612 |
| 159 | AKT3 | 0.19416008 |
| 160 | ROCK1 | 0.18650430 |
| 161 | MKNK1 | 0.18324406 |
| 162 | STK3 | 0.18185956 |
| 163 | PTK2B | 0.18032151 |
| 164 | AKT2 | 0.17939674 |
| 165 | MAP3K13 | 0.17669654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.18359666 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.75738711 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.70820447 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.70492989 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.97498906 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.93377933 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.83471638 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.75537559 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.75432373 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.42689053 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.26632135 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.22805051 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06548625 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05036321 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.98205943 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94630641 |
| 17 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.93164412 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.92045578 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.90402356 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.83477940 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.82100727 |
| 22 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.71777161 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68916874 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.68119253 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.68050484 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.62474174 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.55575439 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.55344992 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.54729468 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.53138576 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.52710450 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49244227 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.44751202 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44463646 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.42412559 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38344185 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.27785864 |
| 38 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.26816924 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22821223 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20784041 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19291333 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18212366 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15413801 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11899849 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08845755 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.06750309 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.01628530 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01083612 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00862019 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.00136042 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98851383 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96882205 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96855024 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.95733221 |
| 55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95716727 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94172932 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93754153 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93385837 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93109764 |
| 60 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91036363 |
| 61 | Tight junction_Homo sapiens_hsa04530 | 0.90762011 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87710305 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86215688 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84494919 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84224611 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.84031933 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77817361 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77594065 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77339149 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76676319 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76473251 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74562567 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74518113 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73107599 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.72926000 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72791305 |
| 77 | GABAergic synapse_Homo sapiens_hsa04727 | 0.69663703 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67964237 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.67532025 |
| 80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66290975 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.65190605 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.64802147 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63008726 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.62659306 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62472765 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61529669 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60437040 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59845855 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58585571 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58097233 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56984083 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.56868477 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55601671 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.55285024 |
| 95 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54716762 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54194609 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53978137 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53901993 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51591614 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51189785 |
| 101 | Long-term depression_Homo sapiens_hsa04730 | 0.48364377 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47240134 |
| 103 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46041840 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45941446 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43760372 |
| 106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43730366 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42763706 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41052279 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38164027 |
| 110 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.37792995 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37030423 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36659587 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.36428369 |
| 114 | Cocaine addiction_Homo sapiens_hsa05030 | 0.33822662 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33506540 |
| 116 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32838877 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32639347 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32227280 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31102440 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.30993724 |
| 121 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.30957879 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29098171 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.28856794 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28845626 |
| 125 | Morphine addiction_Homo sapiens_hsa05032 | 0.28541670 |
| 126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.28402539 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28087317 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26706484 |
| 129 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24931703 |
| 130 | Phototransduction_Homo sapiens_hsa04744 | 0.24655712 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23996770 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23595222 |
| 133 | Salivary secretion_Homo sapiens_hsa04970 | 0.23115583 |
| 134 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.22188967 |
| 135 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22028979 |
| 136 | Renin secretion_Homo sapiens_hsa04924 | 0.21885391 |
| 137 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.21526005 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20515273 |
| 139 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.20099396 |
| 140 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19558628 |
| 141 | Malaria_Homo sapiens_hsa05144 | 0.19318016 |
| 142 | Circadian rhythm_Homo sapiens_hsa04710 | 0.19223088 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19069245 |
| 144 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.19021389 |
| 145 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.18832299 |
| 146 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.17422744 |

